SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950137-06-002437
Filing Date
2006-03-01
Accepted
2006-03-01 16:55:47
Documents
9
Period of Report
2006-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a17862e8vk.htm 8-K 22943
2 EXHIBIT 3.1 a17862exv3w1.htm EX-3.1 41613
3 EXHIBIT 4.1 a17862exv4w1.htm EX-4.1 35368
4 EXHIBIT 10.1 a17862exv10w1.htm EX-10.1 18334
5 EXHIBIT 10.2 a17862exv10w2.htm EX-10.2 18025
6 EXHIBIT 10.3 a17862exv10w3.htm EX-10.3 18038
7 EXHIBIT 10.4 a17862exv10w4.htm EX-10.4 18376
8 EXHIBIT 10.5 a17862exv10w5.htm EX-10.5 18388
9 EXHIBIT 10.6 a17862exv10w6.htm EX-10.6 18296
  Complete submission text file 0000950137-06-002437.txt   211064
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 06656435
SIC: 2836 Biological Products, (No Diagnostic Substances)